Survival Analysis in the Presence of Competing Risks: The Example of Waitlisted Kidney Transplant Candidates

Competing events (or risks) preclude the observation of an event of interest or alter the probability of the event's occurrence and are commonly encountered in transplant outcomes research. Transplantation, for example, is a competing event for death on the waiting list because receiving a transplant may significantly decrease the risk of long‐term mortality. In a typical analysis of time‐to‐event data, competing events may be censored or incorporated into composite end points; however, the presence of competing events violates the assumption of “independent censoring,” which is the basis of standard survival analysis techniques. The use of composite end points disregards the possibility that competing events may be related to the exposure in a way that is different from the other components of the composite. Using data from the Scientific Registry of Transplant Recipients, this paper reviews the principles of competing risks analysis; outlines approaches for analyzing data with competing events (cause‐specific and subdistribution hazards models); compares the estimates obtained from standard survival analysis, which handle competing events as censoring events; discusses the appropriate settings in which each of the two approaches could be used; and contrasts their interpretation.

[1]  M. Verduijn,et al.  The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  V T Farewell,et al.  The analysis of failure times in the presence of competing risks. , 1978, Biometrics.

[3]  L. Teixeira,et al.  The effect of delayed graft function on graft and patient survival in kidney transplantation: an approach using competing events analysis , 2015, Transplant international : official journal of the European Society for Organ Transplantation.

[4]  David W. Hosmer,et al.  Applied Survival Analysis: Regression Modeling of Time-to-Event Data , 2008 .

[5]  Melania Pintilie,et al.  Competing Risks: A Practical Perspective , 2006 .

[6]  Melania Pintilie,et al.  Analysing and interpreting competing risk data , 2007, Statistics in medicine.

[7]  J Crowley,et al.  Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. , 1999, Statistics in medicine.

[8]  H C van Houwelingen,et al.  Analysis of the renal transplant waiting list: application of a parametric competing risk method. , 1998, Transplantation.

[9]  V. Coviello,et al.  Cumulative Incidence Estimation in the Presence of Competing Risks , 2004 .

[10]  M. Mishra,et al.  Significance of panel reactive antibodies in patients requiring kidney transplantation. , 2013, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[11]  E. Schiffrin,et al.  T Regulatory Lymphocytes Prevent Aldosterone-Induced Vascular Injury , 2012, Hypertension.

[12]  H. Krakauer,et al.  Time‐to‐Event Modeling of Competing Risks With Intervening States in Transplantation , 2003, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  H. Tian,et al.  Responses of Crop Water Use Efficiency to Climate Change and Agronomic Measures in the Semiarid Area of Northern China , 2015, PloS one.

[14]  D.,et al.  Regression Models and Life-Tables , 2022 .

[15]  A. Laupacis,et al.  Immune Sensitization and Mortality in Wait-Listed Kidney Transplant Candidates. , 2016, Journal of the American Society of Nephrology : JASN.

[16]  Jeffrey J. Gaynor,et al.  On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples from Clinical Oncology Data , 1993 .

[17]  A. Murray,et al.  Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. , 2005, Journal of the American Society of Nephrology : JASN.

[18]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[19]  Per Kragh Andersen,et al.  Competing Risks and Time‐Dependent Covariates , 2009, Biometrical journal. Biometrische Zeitschrift.

[20]  Jennifer R. Zitzner,et al.  HLA-DQ Barrier: Effects on cPRA Calculations , 2013, Transplantation.

[21]  R. Gray A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk , 1988 .

[22]  William G Williams,et al.  Outcomes and Associated Risk Factors for Aortic Valve Replacement in 160 Children: A Competing-Risks Analysis , 2005, Circulation.

[23]  W. Winkelmayer,et al.  Comparison of Longer‐Term Outcomes After Kidney Transplantation Between Hispanic and Non‐Hispanic Whites in the United States , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  S. Cole,et al.  Competing risk regression models for epidemiologic data. , 2009, American journal of epidemiology.

[25]  M S Pepe,et al.  Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? , 1993, Statistics in medicine.

[26]  H. Putter,et al.  Competing risks in epidemiology: possibilities and pitfalls. , 2012, International journal of epidemiology.

[27]  S. Chevret,et al.  Improving estimates of event incidence over time in populations exposed to other events: application to three large databases. , 2003, Journal of clinical epidemiology.

[28]  B. Kiberd,et al.  Effect of recipient sensitization (peak PRA) on graft outcome in haploidentical living related kidney transplants , 2000, Clinical transplantation.

[29]  C. Jacquelinet,et al.  Individual and Regional Factors of Access to the Renal Transplant Waiting List in France in a Cohort of Dialyzed Patients , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[30]  K. Mizutani HLA mismatches and PRA in kidney retransplants. , 2007, Clinical transplants.

[31]  Carmine Zoccali,et al.  When do we need competing risks methods for survival analysis in nephrology? , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[32]  L. Kucirka,et al.  Association of race and age with survival among patients undergoing dialysis. , 2011, JAMA.

[33]  Hyunsuk Kim,et al.  Elderly Peritoneal Dialysis Compared with Elderly Hemodialysis Patients and Younger Peritoneal Dialysis Patients: Competing Risk Analysis of a Korean Prospective Cohort Study , 2015, PloS one.

[34]  Qi Jiang,et al.  Illustrating the Impact of a Time-Varying Covariate With an Extended Kaplan-Meier Estimator , 2005 .

[35]  E. Schiffrin T lymphocytes: a role in hypertension? , 2010, Current opinion in nephrology and hypertension.

[36]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[37]  P. T. Coates,et al.  Effects of Body Mass Index at Transplant on Outcomes of Kidney Transplantation , 2007, Transplantation.

[38]  W. Willett,et al.  Risk factors for mortality in the nurses' health study: a competing risks analysis. , 2011, American journal of epidemiology.

[39]  H Putter,et al.  Tutorial in biostatistics: competing risks and multi‐state models , 2007, Statistics in medicine.

[40]  D. Segev,et al.  Trends in the Inactive Kidney Transplant Waitlist and Implications for Candidate Survival , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[41]  W. Winkelmayer,et al.  Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States. , 2013, Clinical journal of the American Society of Nephrology : CJASN.